Freeline Presents Data Highlighting Platform Technology at the American Society of Gene and Cell Therapy Annual Meeting 2021
May 11, 2021 07:00 ET
|
Freeline Therapeutics
LONDON, May 11, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene...
EHang Holdings to Participate at Upcoming Investor Conferences
May 10, 2021 09:36 ET
|
EHang Holdings Limited
GUANGZHOU, China, May 10, 2021 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (AAV) technology platform company,...
Shape Therapeutics Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 04, 2021 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced two abstracts...
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021
April 27, 2021 16:31 ET
|
Freeline Therapeutics
LONDON, April 27, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene...
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
April 21, 2021 16:01 ET
|
Freeline Therapeutics
LONDON, April 21, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative...
EHang Reports Fourth Quarter and Full Year 2020 Unaudited Financial Results
April 16, 2021 07:05 ET
|
EHang Holdings Limited
- Robust annual revenue growth despite pandemic impact- Record quarterly and annual adjusted gross margin since inception- Expanded well-rounded product portfolio to capture more market opportunities ...
CAAC Established EH216 Type Certification Team to Further Advance Certification Process
April 16, 2021 06:25 ET
|
EHang Holdings Limited
GUANGZHOU, China, April 16, 2021 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform...
Freeline Reports Full Year 2020 Financial Results and Business Highlights
March 31, 2021 16:02 ET
|
Freeline Therapeutics
Plans to have three AAV gene therapy programs in the clinic by year-end 2021 Data from FLT180a Phase 1/2 trial for Hemophilia B demonstrated potential for durable normalization of Factor IX...
EHang to Report Fourth Quarter and Full Year 2020 Unaudited Financial Results on Friday, April 16, 2021
March 31, 2021 09:12 ET
|
EHang Holdings Limited
GUANGZHOU, China, March 31, 2021 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
Freeline to Present at Upcoming Investor Conferences
March 30, 2021 16:01 ET
|
Freeline Therapeutics
LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene...